| 期 |
栏目 |
标题 |
文件 |
| 卷 81, 编号 9 (2009) |
Editorial |
Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment |
|
| 卷 82, 编号 8 (2010) |
Editorial |
Risk factors for venous thromboembolic events and their association with D-dimer level |
|
| 卷 83, 编号 3 (2011) |
Editorial |
Genetic polymorphisms coding hemostasis protein synthesis and venous thromboembolic complications in Moscow population |
|
| 卷 83, 编号 6 (2011) |
Editorial |
Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage |
|
| 卷 83, 编号 8 (2011) |
Editorial |
Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins |
|
| 卷 83, 编号 12 (2011) |
Editorial |
Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications |
|
| 卷 93, 编号 12 (2021) |
Original articles |
The prevalence of osteoarthritis and its association with geriatric syndromes in people over 65: data from the Russian epidemiological study EVKALIPT |
(Rus)
|
| 卷 94, 编号 1 (2022) |
Original articles |
The prevalence of anemia and its associations with other geriatric syndromes in subjects over 65 years old: data of Russian epidemiological study EVKALIPT |
(Rus)
|
| 卷 94, 编号 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
(Rus)
|
| 卷 95, 编号 12 (2023) |
Original articles |
Real-world experience with netakimab in the treatment of spondyloarthritis |
(Rus)
|
